Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Dec
21
2023
Pharmaceutical Companies Have Rights if the Federal Government Seized their Patents Sheppard, Mullin, Richter & Hampton LLP
Dec
21
2023
Inherent Limitations in Prior Patents can Lead to Obviousness-Type Double-Patenting Mintz
Dec
21
2023
FDA Announces Updated Instructions for Serious Adverse Event Reporting for Cosmetic Products ArentFox Schiff LLP
Dec
21
2023
FSA Assesses Oyster Import Risks Keller and Heckman LLP
Dec
21
2023
APHIS Extends Comment Period on Proposed Exemptions for Genetically Modified Plants Keller and Heckman LLP
Dec
21
2023
Australia and New Zealand Consult on the First Cell-Cultured Meat Application Keller and Heckman LLP
Dec
20
2023
2023: Another Year Chock Full of Challenges for FDA Mintz
Dec
20
2023
Boosting Biotech: New York City Revives Tax Credits for Emerging Companies Mintz
Dec
20
2023
A Win for Skinny Labels: Insights for Enforcing Use Patents Squire Patton Boggs (US) LLP
Dec
19
2023
Health Care Workers Engaged in Treatment, Payment, or Operations Excluded by BIPA Epstein Becker & Green, P.C.
Dec
19
2023
FDA Issues Final Guidance Document on MoCRA Requirements for Cosmetic Facility Registration and Cosmetic Product Listing, Also Opens Electronic Portal for Submissions Keller and Heckman LLP
Dec
19
2023
The Tax Implications of Purchasing Craft Producers in the First Half of 2024 McDermott Will & Emery
Dec
19
2023
Investigation Into Lead-Contaminated Applesauce Continues Keller and Heckman LLP
Dec
18
2023
Cinnamon and Spice but Not Necessarily Nice ArentFox Schiff LLP
Dec
18
2023
The ‘One Substance, One Assessment Package’: Implications, Upcoming Pilot Project, Impact on EFSA Keller and Heckman LLP
Dec
15
2023
November 2023 Bounty Hunter Plaintiff Claims Keller and Heckman LLP
Dec
15
2023
Cell-Cultivated Meats: Nutrition, Safety, and Global Growth Womble Bond Dickinson (US) LLP
Dec
15
2023
FDA Proposes Reorganization for HFP and ORA Keller and Heckman LLP
Dec
15
2023
Unable to Individually Trace PFAS to Manufacturers, Sixth Circuit Dismisses PFAS Class Action Foley & Lardner LLP
Dec
14
2023
President Seeks More Antitrust Scrutiny of Health Care Transactions Epstein Becker & Green, P.C.
Dec
14
2023
If the Label Is Skinny Enough – No Inducement Under Hatch-Waxman McDermott Will & Emery
Dec
14
2023
EPA’s Proposed Registration of a Sprayable RNAi Biopesticide — A Conversation with Meibao Zhuang, Ph.D. [Podcast] Bergeson & Campbell, P.C.
Dec
14
2023
ECHA Calls for Evidence on Certain Chromium (VI) Substances Bergeson & Campbell, P.C.
Dec
13
2023
Federal Circuit Evaluates Impact of the Final Written Decision (FWD) in a Parallel Inter-Partes Review (IPR) on District Court’s decision of Invalidity and Infringement Sheppard, Mullin, Richter & Hampton LLP
Dec
13
2023
AMCC Awards Five Integrated Licenses, Chaos to Follow Bradley Arant Boult Cummings LLP
Dec
13
2023
FDA Announces Draft Supplemental Guidance on Menu Labeling Keller and Heckman LLP
Dec
13
2023
M&A Primer for Emerging Healthy F&B Companies Foley & Lardner LLP
Dec
12
2023
US House Introduces Bipartisan Feed Ingredient Bill Keller and Heckman LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins